Cancer lab firm names Dave Daly to its board

Cancer-focused genetic testing services firm NeoGenomics, based in Fort Myers, Fla., has named Singular Genomics President and COO Dave Daly to its board, according to a Nov. 14 Business Observer report.

Advertisement
Marcus Robertson

Prior to joining Singular Genomics, Daly was CEO at cancer screening company Thrive Earlier Detection, which was acquired by Exact Sciences Corporation for $2.15 billion earlier this year.

Daly’s appointment to the board took effect on Nov. 10, according to the report.

From fragmented fixes to systemwide control: UVA Health’s approach to drug shortage management and supply chain transformation

Recommended Live Webinar on Jan 27, 2026 11:00 AM - 12:00 PM CST

Advertisement

Next Up in Lab

Advertisement

Comments are closed.